These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 38148953)
1. Transmembrane and Ubiquitin-Like Domain-Containing 1 Promotes Glioma Growth and Indicates Unfavorable Prognosis. Liu Y; Cai C; Wu K; Hu L Int J Genomics; 2023; 2023():3318171. PubMed ID: 38148953 [TBL] [Abstract][Full Text] [Related]
2. Tmub1 Suppresses Hepatocellular Carcinoma by Promoting the Ubiquitination of ΔNp63 Isoforms. Fu H; Zhang Y; Chen J; Zhou B; Chen G; Chen P Mol Ther Oncolytics; 2020 Sep; 18():126-136. PubMed ID: 32671188 [TBL] [Abstract][Full Text] [Related]
3. TMUB1 Correlated with Immune Infiltration Is a Prognostic Marker for Colorectal Cancer. Hao T; Yu H; Huang D; Liu Q Dis Markers; 2022; 2022():5884531. PubMed ID: 35928927 [TBL] [Abstract][Full Text] [Related]
4. Transmembrane and Ubiquitin-Like Domain Containing 1 Protein (TMUB1) Negatively Regulates Hepatocellular Carcinoma Proliferation via Regulating Signal Transducer and Activator of Transcription 1 (STAT1). Chen Y; Fu H; Zhang Y; Chen P Med Sci Monit; 2019 Dec; 25():9471-9482. PubMed ID: 31827061 [TBL] [Abstract][Full Text] [Related]
5. TMUB1 expression is associated with the prognosis of colon cancer and immune cell infiltration. Lu Y; Wang K; Peng Y; Zhang J; Ju Q; Xu Q; Ouyang M; He Z PeerJ; 2023; 11():e16334. PubMed ID: 38025742 [TBL] [Abstract][Full Text] [Related]
6. Transmembrane and ubiquitin-like domain-containing protein 1 (Tmub1/HOPS) facilitates surface expression of GluR2-containing AMPA receptors. Yang H; Takagi H; Konishi Y; Ageta H; Ikegami K; Yao I; Sato S; Hatanaka K; Inokuchi K; Seog DH; Setou M PLoS One; 2008 Jul; 3(7):e2809. PubMed ID: 18665261 [TBL] [Abstract][Full Text] [Related]
7. A nuclear transport-related gene signature combined with IDH mutation and 1p/19q codeletion better predicts the prognosis of glioma patients. Zhu Z; Lan Y; Wang L; Ge J; Wang J; Liu F; He Z; Zhang H; Luo M; Lin D; Tan Y; Xu Y; Luo T BMC Cancer; 2020 Nov; 20(1):1072. PubMed ID: 33167941 [TBL] [Abstract][Full Text] [Related]
8. CCDC103 as a Prognostic Biomarker Correlated with Tumor Progression and Immune Infiltration in Glioma. Xu Z; Xu H; Chen X; Huang X; Tian J; Zhao J; Liu B; Shi F; Wu J; Pu J Onco Targets Ther; 2023; 16():819-837. PubMed ID: 37873495 [TBL] [Abstract][Full Text] [Related]
9. CCAAT/enhancer-binding protein β regulates interleukin-6-induced transmembrane and ubiquitin-like domain containing 1 gene expression in hepatocytes. Liu M; Yuan T; Liu H; Chen P Mol Med Rep; 2014 Oct; 10(4):2177-83. PubMed ID: 25109894 [TBL] [Abstract][Full Text] [Related]
10. Microarray analysis reveals Tmub1 as a cell cycle-associated protein in rat hepatocytes. Fu H; Xu J; Chen J; Li G; Zhao X; Chen P Mol Med Rep; 2018 Mar; 17(3):4337-4344. PubMed ID: 29344642 [TBL] [Abstract][Full Text] [Related]
11. A 1p/19q Codeletion-Associated Immune Signature for Predicting Lower Grade Glioma Prognosis. Xu J; Liu F; Li Y; Shen L Cell Mol Neurobiol; 2022 Apr; 42(3):709-722. PubMed ID: 32894375 [TBL] [Abstract][Full Text] [Related]
12. Transmembrane and ubiquitin-like domain containing 1 (Tmub1) regulates locomotor activity and wakefulness in mice and interacts with CAMLG. Zhang W; Savelieva KV; Suwanichkul A; Small DL; Kirkpatrick LL; Xu N; Lanthorn TH; Ye GL PLoS One; 2010 Jun; 5(6):e11261. PubMed ID: 20582322 [TBL] [Abstract][Full Text] [Related]
13. MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma. Yang S; Yuan Y; Ren W; Wang H; Zhao Z; Zhao H; Zhao Q; Chen X; Jiang X; Zhang L Front Oncol; 2022; 12():1004324. PubMed ID: 36465369 [TBL] [Abstract][Full Text] [Related]
14. TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations. Arita H; Matsushita Y; Machida R; Yamasaki K; Hata N; Ohno M; Yamaguchi S; Sasayama T; Tanaka S; Higuchi F; Iuchi T; Saito K; Kanamori M; Matsuda KI; Miyake Y; Tamura K; Tamai S; Nakamura T; Uda T; Okita Y; Fukai J; Sakamoto D; Hattori Y; Pareira ES; Hatae R; Ishi Y; Miyakita Y; Tanaka K; Takayanagi S; Otani R; Sakaida T; Kobayashi K; Saito R; Kurozumi K; Shofuda T; Nonaka M; Suzuki H; Shibuya M; Komori T; Sasaki H; Mizoguchi M; Kishima H; Nakada M; Sonoda Y; Tominaga T; Nagane M; Nishikawa R; Kanemura Y; Kuchiba A; Narita Y; Ichimura K Acta Neuropathol Commun; 2020 Nov; 8(1):201. PubMed ID: 33228806 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathological analysis of HOXD4 expression in diffuse gliomas and its correlation with Zhao XW; Zhan YB; Bao JJ; Zhou JQ; Zhang FJ; Bin Y; Bai YH; Wang YM; Zhang ZY; Liu XZ Oncotarget; 2017 Dec; 8(70):115657-115666. PubMed ID: 29383189 [TBL] [Abstract][Full Text] [Related]
16. Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylation. Shi C; Wang Y; Wu M; Chen Y; Liu F; Shen Z; Wang Y; Xie S; Shen Y; Sang L; Zhang Z; Gao Z; Yang L; Qu L; Yang Z; He X; Guo Y; Pan C; Che J; Ju H; Liu J; Cai Z; Yan Q; Yu L; Wang L; Dong X; Xu P; Shao J; Liu Y; Li X; Wang W; Zhou R; Zhou T; Lin A Nat Commun; 2022 Nov; 13(1):6951. PubMed ID: 36376293 [TBL] [Abstract][Full Text] [Related]
17. Interfering with Gu S; Shu L; Zhou L; Wang Y; Xue H; Jin L; Xia Z; Dai X; Gao P; Cheng H Ann Transl Med; 2022 Dec; 10(23):1277. PubMed ID: 36618798 [TBL] [Abstract][Full Text] [Related]
18. IL-6 induction of hepatocyte proliferation through the Tmub1-regulated gene pathway. Liu M; Liu H; Wang X; Chen P; Chen H Int J Mol Med; 2012 Jun; 29(6):1106-12. PubMed ID: 22426572 [TBL] [Abstract][Full Text] [Related]
19. Expression and Prognostic Role of PANK1 in Glioma. Zhao Z; Xu X; Ma S; Li L Comb Chem High Throughput Screen; 2024; 27(5):715-724. PubMed ID: 37138430 [TBL] [Abstract][Full Text] [Related]
20. Tmub1 negatively regulates liver regeneration via inhibiting STAT3 phosphorylation. Fu H; Dong R; Zhang Y; Xu J; Liu M; Chen P Cell Signal; 2019 Mar; 55():65-72. PubMed ID: 30610893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]